1887

Chapter 1 : Infectious Causes of Chronic Disease: from Hypothesis to Proof

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in
Zoomout

Infectious Causes of Chronic Disease: from Hypothesis to Proof, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815486/9781555814304_Chap01-1.gif /docserver/preview/fulltext/10.1128/9781555815486/9781555814304_Chap01-2.gif

Abstract:

The initial proof of an infectious organism’s causal link to a chronic disease often meets resistance to acceptance and requires several years of research by various teams of researchers to isolate the organism, develop a reliable clinical test, and document the association of the organism with human disease through clinical studies. Thus, identifying the “best practices” behind successful medical documentation of infectious etiologies of chronic disease will help streamline and, it is hoped, expedite the success of the process. In fact, there is more than passive resistance to studies of possible infectious causes of chronic disease. Infectious diseases are often clinically identified based on characteristic signs of acute infection, although clearly noninfectious diseases can closely mimic the signs of infectious diseases (e.g., allergic drug reactions). Some researchers who have proposed connecting a new infectious agent to a chronic disease have taken the drastic step of testing the final proof of Koch’s postulates on themselves, including inducing ulcers by swallowing or self-inducing (fatal) yellow fever through exposure to infected mosquitoes to test a vector hypothesis. The combination of creative, novel thinking and essential but-not-very-glamorous rigorous diagnostic test development (e.g., assay validation and standards) makes the pursuit of infectious etiologies for chronic diseases an exciting yet challenging pursuit.

Citation: Carbone K. 2009. Infectious Causes of Chronic Disease: from Hypothesis to Proof, p 1-8. In Fratamico P, Smith J, Brogden K (ed), Sequelae and Long-Term Consequences of Infectious Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555815486.ch1

Key Concept Ranking

Infectious Diseases
0.4588888
Severe Acute Respiratory Syndrome
0.45593017
Infectious Pathogens
0.4384843
Immune Systems
0.4135695
0.4588888
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555815486.ch01
1. Alter, A.,, A. Alcaïs,, L. Abel, and, E. Schurr. 2008. Leprosy as a genetic model for susceptibility to common infectious diseases. Hum. Genet. 123:227235.
2. Alzheimer’s Association. 2008. 2008 Alzheimer’s disease facts and figures. Alzheimers Dement. 4:110133.
3. Ammann, A. J.,, M. J. Cowan,, D. W. Wara,, P. Weintrub,, S. Dritz,, H. Goldman, and, H. A. Perkins. 1983. Acquired immunodeficiency in an infant: possible transmission by means of blood products. Lancet i:956958.
4. Antonelli, A.,, C. Ferri,, M. Galeazzi,, C. Giannitti,, D. Mmanno,, G. Mieli-Vergani,, E. Menegatti,, T. Olivieri,, M. Puoti,, C. Palazzi,, D. Roccatello,, D. Vergani,, P. Sarzi-Puttini, and, F. Atzeni. 2008. HCV infection: pathogenesis, clinical manifestations and therapy. Clin. Exp. Rheumatol. 26(Suppl. 48):S39S47.
5. Barré-Sinoussi, F.,, J. C. Chermann,, F. Rey,, M. T. Nugeyre,, S. Chamaret,, J. Gruest,, C. Dauguet,, C. Axler-Blin,, F. Vézinet-Brun,, C. Rouzioux,, W. Rozenbaum, and, L. Montagnier. 1983. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220:868871.
6. Berger, J. R. 2007. Progressive multifocal encephalopathy. Curr. Neurol. Neurosci. Rep. 7:461469.
7. Bonnet, M. C.,, A. Dutta,, C. Weinberger, and, S. A. Plotkin. 2006. Mumps vaccine virus strains and aseptic meningitis. Vaccine 24:70377045.
8. Brennan, R. O.,, and D. T. Durack. 1981. Gay compromise syndrome. Lancet ii:13381339.
9. Broder, S.,, and R. C. Gallo. 1984. A pathogenic retrovirus (HTLV-III) linked to AIDS. N. Engl. J. Med. 311:12921297.
10. Burgdorfer, W. 1994. Discovery of the Lyme disease spirochete and its relation to tick vectors. Yale J. Biol. Med. 57:515520.
11. Reference deleted.
12. Carbone, A.,, A. Gloghini, and, G. Dotti. 2008. EBV-associated lymphoproliferative disorders: classification and treatment. Oncologist 13:577585.
13. CDC. 1981. Kaposi’s sarcoma and Pneumocystis pneumonia among homosexual men—New York City and California. MMWR Morb. Mortal. Wkly. Rep. 30:305308.
14. CDC. 1982. Update on acquired immune deficiency syndrome (AIDS)–United States. MMWR Morb. Mortal. Wkly. Rep. 31:507508, 513514.
15. Curran, J. W.,, D. N. Lawrence,, H. Jaffe,, J. E. Kaplan,, L. D. Zyla,, M. Chamberland,, R. Weinstein,, K. J. Lui,, L. B. Schonberger,, T. J. Spira,, W. J. Alexander,, G. Swinger,, A. Ammann,, S. Solomon,, D. Auerbach,, D. Mildvan,, R. Stoneburner,, J. M. Jason,, H. W. Haverkos, and, B. L. Evatt. 1984. Acquired immunodeficiency syndrome (AIDS) associated with transfusions. N. Engl. J. Med. 310:6975.
16. Curtis, L. T. 2008. Prevention of hospital-acquired infections: review of non-pharmacological interventions. J. Hosp. Infect. 69:204219.
17. DeStefano, F. 2007. Vaccines and autism: evidence does not support a causal association. Clin. Pharmacol. Ther. 86:756759.
18. de The, G. 1995. Viruses and human cancers: challenges for preventative strategies. Environ. Health Perspect. 103(Suppl. 8):269273.
19. Reference deleted.
20. Duloy, A. M.,, E. A. Calhoun, and, J. Q. Clemens. 2007. Economic impact of chronic prostatitis. Curr. Urol. Rep. 8:336339.
21. Reference deleted.
22. Francis, T., Jr. 1934. Transmission of influenza by a filterable virus. Science 80:457459.
23. Francis, T., Jr.,, and T. P. Magill. 1935. Cultivation of human influenza virus in an artificial medium. Science 82:353354.
24. Frank, D. N.,, and N. R. Pace. 2008. Gastrointestinal microbiology enters the metagenomics era. Curr. Opin. Gastroenterol. 24:410.
25. Gao, S. J.,, and P. S. Moore. 1996. Molecular approaches to the identification of unculturable infectious agents. Emerg. Infec. Dis. 2:159167.
26. Girschick, H. J.,, L. Guilherme,, R. D. Inman,, K. Latsch,, M. Rihl,, Y. Sherer,, Y. Shoenfeld,, H. Zeidler,, S. Arienti, and, A. Doria. 2008. Bacterial triggers and autoimmune rheumatic diseases. Clin. Exp. Rheumatol. 26(Suppl. 48):S12S17.
27. Gottlieb, M. S.,, R. Schroff,, H. M. Schanker,, J. D. Weisman,, P. T. Fan,, R. A. Wolf, and, A. Saxon. 1981. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N. Engl. J. Med. 305:14251431.
28. Hammer, S. M.,, J. J. Eron, Jr.,, P. Reiss,, R. T. Schooley,, M. A. Thompson,, S. Walmsley,, P. Cahn,, M. A. Fischl,, J. M. Gatell,, M. S. Hirsch,, D. M. Jacobsen,, J. S. Monaer,, D. D. Richman,, P. G. Yeni,, P. A. Volberding, and International AIDS Society–USA. 2008. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society–USA panel. JAMA 300:555570.
29. Hutton, D. W.,, D. Tan,, S. K. So, and, M. L. Brandeau. 2007. Cost-effectiveness of screening and vaccinating Asian and Pacific Islander adults for hepatitis B. Ann. Intern. Med. 147:460469.
30. Ieven, M. 2007. Currently used nucleic acid amplification tests for the detection of viruses and atypicals in acute respiratory infections. J. Clin. Virol. 40:259276.
31. Jaffe, H. W.,, K. Choi,, P. A. Thomas,, H. W. Haverkos,, D. M. Auerbach,, M. E. Guinan,, M. F. Rogers,, T. J. Spira,, W. W. Darrow,, M. A. Kramer,, S. M. Friedman,, J. M. Monroe,, A. E. Friedman-Kien,, L. J. Laubenstein,, M. Marmor,, B. Safai,, S. K. Dritz,, S. J. Crispi,, S. L. Fannin,, J. P. Orkwis,, A. Kelter,, W. R. Rushing,, S. B. Thacker, and, J. W. Curran. 1983. National case-control study of Kaposi’s sarcoma and Pneumocystis carinii pneumonia in homosexual men: part 1. Epidemiological results. Ann. Intern. Med. 99:145151.
32. Jahan, S.,, A. M. Al Saigul,, M. A. Abu Baker,, A. O. Altaya, and, S. A. Hamed. 2008. Measles outbreak in Qassim, Saudi Arabia 2007: epidemiology and evaluation of the outbreak response. J. Public Health [Epub ahead of print.] doi:10.1093/pubmed/fdn070.
33. Johnson, L.,, and R. B. Stricker. 2004. Treatment of Lyme disease: a medicolegal assessment. Expert Rev. Anti Infect. Ther. 2:533557.
34. Khan, S.,, and C. A. Amedia, Jr. 2008. Economic burden of chronic kidney disease. J. Eval. Clin. Pract. 14:422434.
35. Kim, J. J.,, and S. J. Goldie. 2008. Health and economic implications of HPV vaccination in the United States. N. Engl. J. Med. 359:821831.
36. Kinross, J. M.,, A. C. von Roon,, E. Holmes,, A. Darzi, and, J. K. Nicholson. 2008. The human gut microbiome: implications for future health care. Curr. Gastroenterol. Rep. 10:396403.
37. Klouche, M.,, and U. Schröder. 2008. Rapid methods for diagnosis of bloodstream infections. Clin. Chem. Lab. Med. 46:888908.
38. Konturek, J. W. 2003. Discovery by Jaworski of Helicobacter pylori and its pathogenetic role in peptic ulcer, gastritis and gastric cancer. J. Physiol. Pharmacol. 54(Suppl. 3):2341.
39. Kuramitsu, H. K.,, X. He,, R. Lux,, M. H. Anderson, and, W. Shi. 2007. Interspecies interactions within oral microbial communities. Microbiol. Mol. Biol. Rev. 71:653670.
40. Lalvani, A.,, P. L. Meroni,, K. A. Millington,, M. L. Modolo,, M. Plebani,, A. Ticani,, D. Villalta,, A. Doria, and, A. Chiradello. 2008. Recent advances in diagnostic technology: applications in autoimmune and infectious diseases. Clin. Exp. Rheumatol. 26(Suppl. 48):S62S66.
41. Lee, Y. C.,, J. T. Lin,, H. M. Wu,, T. Y. Liu,, M. F. Yen,, H. M. Chiu,, H. P. Wang,, M. S. Wu, and, T. Hsiu-His Chen. 2007. Cost-effectiveness analysis between primary and secondary preventative strategies for gastric cancer. Cancer Epidemiol. Biomarkers Prev. 16:875885.
42. Liao, L.,, L. A. Allen, and, D. J. Whellan. 2008. Economic burden of heart failure in the elderly. Pharmacoeconomics 26:447462.
43. Maldonado, Y. A. 2008. Impact of fetal and neonatal viral (and parasitic) infections on later development and disease outcome. Nestle Nutr. Workshop Ser. Pediatr. Program 61:225242.
44. Masur, H.,, M. A. Michelis,, J. B. Greene,, I. Onorato,, R. A. Stouwe,, R. S. Holzman,, G. Wormser,, L. Brettman,, M. Lange,, H. W. Murray, and, S. Cunningham-Rundles. 1981. An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N. Engl. J. Med. 305:14311438.
45. Maxwell, E. S.,, T. G. Ward, and, T. E. Van Metre. 1949. The relation of influenza virus and bacteria in the etiology of pneumonia. J. Clin. Investig. 28:307318.
46. McDonald, J. C.,, D. L. Moore, and, P. Quennec. 1989. Clinical and epidemiological features of mumps meningoencephalitis and possible vaccine-related disease. Pediatr. Infect. Dis. J. 8:751755.
47. McFarland, L. V. 2008. State-of-the-art of irritable bowl syndrome and inflammatory bowel disease research in 2008. World J. Gastroenterol. 14:26252629.
48. McKellar, M. S.,, S. F. Callens, and, R. Colebunders. 2008. Pediatric HIV infection: the state of antiretroviral therapy. Expert. Rev. Anti Infect. Ther. 6:167180.
49. Mikhailovich, V.,, D. Gryadunov,, A. Kolchinsky,, A. A. Makarov, and, A. Zasedatelev. 2008. DNA microarrays in the clinic: infectious diseases. Bioessays 30:637682.
50. Morris, J. 1993. Originality: who is to judge? Lancet 342:930.
51. National Cancer Institute. December 2007, posting date. Cancer trends progress report–2007 update. National Cancer Institute, NIH, DHHS, Bethesda, MD. http://progressreport.cancer.gov.
52. Nature Publishing Group. 2008. To thwart disease, apply now. Nature 453:823.
53. Nichol, G.,, D. T. Dennis,, A. C. Steere,, R. Lightfoot,, G. Wells,, B. Shea, and, P. Tugwell. 1998. Test-treatment strategies for patients suspected of having Lyme disease: a cost effectiveness analysis. Ann. Intern. Med. 128:3748.
54. Olitsky, P. K.,, and F. L. Gates. 1920. Experimental study of the nasopharyngeal secretions from influenza patients. JAMA 74:14971499.
55. Planz, O.,, K. A. Bechter, and, M. Schwemmle. 2002. Human Borna disease virus infection, p. 179–227. In K. M. Carbone (ed.), Borna Disease Virus and Its Role in Neurobehavioral Disease. ASM Press, Washington, DC.
56. Puius, Y. A.,, and R. A. Kalish. 2008. Lyme arthritis: pathogenesis, clinical presentation and management. Infect. Dis. Clin. North Am. 22:289300.
57. Reed, W.,, J. Carroll, and, A. Agramonte. 1901. The etiology of yellow fever: an additional note. JAMA 36:431440.
58. Rima, B. K.,, and W. P. Duprex. 2005. Molecular mechanisms of measles virus persistence. Virus Res. 111:132147.
59. Rogowski, W. H.,, S. C. Hartz, and, J. H. John. 2008. Clearing up the hazy road from bench to bedside: a framework for integrating the fourth hurdle into translational medicine. BMC Health Serv. Res. 8:194.
60. Russel, S. 2004. The economic burden of illness for households in developing countries: a review of studies focusing on malaria, tuberculosis and human immunodeficiency virus/acquired immunodeficiency syndrome. Am. J. Trop. Med. Hyg. 71(2 Suppl.):147155.
61. Satija, N.,, and S. K. Lal. 2007. The molecular biology of SARS coronavirus. Ann. N. Y. Acad. Sci. 1102:2638.
62. Saulsbury, F. T.,, and J. A. Katzmann. 1990. Prevalence of antibody to Borrelia burgdorferi in children with juvenile rheumatoid arthritis. J. Rheumatol. 17:11931194.
63. Schneider, T.,, V. Moos,, C. Loddenkemper,, T. Marth,, F. Fenollar, and, D. Raoult. 2008. Whipple’s disease: new aspects of pathogenesis and treatment. Lancet Infect. Dis. 8:179190.
64. Schrenzel, J. 2007. Clinical relevance of new diagnostic methods for bloodstream infections. Int. J. Antimicrob. Agents 30(Suppl. 1):S2S6.
65. Shah, K. V. 2007. SV40 and human cancer: a review of recent data. Int. J. Cancer 120:215223.
66. Sherrick, A. D.,, L. R. Brown,, G. F. Harms, and, J. L. Myers. 1994. The radiographic findings of fibrosing mediastinitis. Chest 106:484489.
67. Skowronski, D. M.,, C. Astell,, R. C. Brunham,, D. E. Low,, M. Petric,, R. L. Roper,, P. J. Talbot,, T. Tam, and, L. Babiuk. 2005. Severe acute respiratory syndrome (SARS): a year in review. Ann. Rev. Med. 56:357381.
68. Steere, A. C. 2008. Reply to Stricker and Johnson. Clin. Infect. Dis. 47:11121113.
69. Stricker, R. B.,, and L. Johnson. 2008. Serological tests for Lyme disease: more smoke and mirrors. Clin. Infect. Dis. 47:11111112.
70. Tabenberger, J. D.,, J. V. Hultin, and, D. M. Morens. 2007. Discovery and characterizations of the 1918 pandemic influenza virus in historical context. Antivir. Ther. 12:581591.
71. Tognotti, E. 2003. Scientific triumphalism and learning from facts: bacteriology and the “Spanish flu” challenge of 1918. Soc. Hist. Med. 16:97110.
72. Urbanski, P.,, A. Wolf, and, W. H. Herman. 2008. Cost-effectiveness of diabetes education. J. Am. Diet. Assoc. 108(4 Suppl. 1):S6S11.
73. Vogt, M.,, R. Lüthy, and, W. Siegenthaler. 1982. GRID syndrome. Dtsch. Med. Wochenschr. 107:15391542.
74. Voisset, C.,, R. A. Weiss, and, D. J. Griffiths. 2008. Human RNA “rumor” viruses: the search for novel human retroviruses in chronic disease. Microbiol. Mol. Biol. Rev. 72:157196.
75. Weiner, S. J.,, and S. Neragi-Miandoab. 2008. Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors. J. Cancer. Res. Clin. Oncol. [Epub ahead of print.] doi: 10.1007/s00432-008-0444-9.
76. Wilske, B.,, V. Fingerle, and, U. Schulte-Spechtel. 2007. Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol. Med. Microbiol. 49:1221.
77. World Health Organization. 1999. WHO report on infectious diseases: removing obstacles to healthy development. http://www.who.int/infectious-disease-report/index-rpt99.html.
78. Zampieri, C. A.,, N. J. Sullivan, and, G. J. Nabel. 2007. Immunopathology of highly virulent pathogens: insights from Ebola virus. Nat. Immunol. 8:11591164.

Tables

Generic image for table
Table 1.

Studies of economic burdens of chronic diseases in the United States

Citation: Carbone K. 2009. Infectious Causes of Chronic Disease: from Hypothesis to Proof, p 1-8. In Fratamico P, Smith J, Brogden K (ed), Sequelae and Long-Term Consequences of Infectious Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555815486.ch1

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error